Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma (Q39336282)

11 September 2017

Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma (English)

1 reference

11 September 2017

Toshinari Mikami

1

1 reference

11 September 2017

Tomohiro Hada

2

1 reference

11 September 2017

Naoyuki Chosa

3

1 reference

11 September 2017

Akira Ishisaki

4

1 reference

11 September 2017

Harumi Mizuki

5

1 reference

11 September 2017

Yasunori Takeda

6

1 reference

11 September 2017

5 June 2012

1 reference

Journal of Oral Pathology & Medicine

11 September 2017

1 reference

11 September 2017

42

1 reference

11 September 2017

2

1 reference

11 September 2017

133-139

1 reference

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

The candidate Wilms' tumour gene is involved in genitourinary development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Expression of WT1 protein and correlation with cellular proliferation in glial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

The Wilms' tumor suppressor WT1 is associated with melanoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Tumor cell invasion and survival in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01182.X

10.1111/J.1600-0714.2012.01182.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference